Product Reports Resources Pricing Login Book a demo

Nicolab

Health Tech & Medtech · Amsterdam, Netherlands · Founded 2015

Nicolab developed StrokeViewer® to enable fast and accurate image analysis that helps physicians in making well-informed decisions MoreLess

Developer of an AI-powered clinical decision support system designed to offer a complete assessment of relevant imaging biomarkers. The company's system assesses all-important biomarkers on emergency computed tomography and notifies of findings, enabling physicians to aid in the timely and accurate triaging of stroke victims. Keywords: Healthcare Devices, Services, Supplies, Images Analysis, Neuroimaging Data Analysis, Neuroimaging Data Management, Neurological Trials, Neurovascular Images Analysis, Neurovascular Imaging.

Company overview

Nicolab company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2015
Headquarters
Amsterdam, Netherlands
Employees
43
Open positions
None listed
Dealroom signal
66.5
client focusb2btechnologyArtificial IntelligencetechnologyHardwaretechnologyBig DatatechnologyDeep TechtechnologyMachine LearningtechnologyComputer Visionsub industryHealth Platformbusiness modelManufacturingbusiness modelSaaSindustryHealthsectorMedical EducationsectorNeurologysectorRadiology

Valuation & funding

Nicolab funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEEDEquity / VC Jun 2024 $2.1M $46M NLC Health Ventures
EARLY VCEquity / VC Dec 2023 $275K $46M NLC Health Ventures
GRANTOther financing Oct 2022 $2.2M European Innovation Council
OtherOther financing Apr 2021 $9.2M Canaccord Genuity Group
EARLY VCEquity / VC Aug 2018 $3.3M $13M Undisclosed
GRANTOther financing Jan 2016 European Innovation Council
SEEDEquity / VC Nov 2015 NLC Health Ventures
SPINOUTOther financing Jan 2015 University of Amsterdam · Amsterdam UMC
Showing 8 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $7.5M 0% 43
2025 $7.5M 0% 48
2024 $7.5M 0% 53
2023 $7.5M +7.1% 58
2022 $7M +118.8% 50
2021 $3.2M +28% 49
2020 $2.5M 29
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Nicolab website traffic

Latest recorded traffic for Nicolab is 3.8K monthly website visits, up 137.5% over the last three months. Nicolab's team declined 10.4% over the past year.

Latest monthly visits3.8K 3-month web change+137.5% 1-year team growth-10.4%
Monthly website visits108 observations · Feb 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Nicolab compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Nicolab's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Nicolab's cap table

Sourced from Dealroom's funding and investor records.

Seed 2 investors entered at this stage
NLC Health Ventures
European Innovation Council
Other known 4 additional known investors
Amsterdam UMC
Canaccord Genuity Group
University of Amsterdam
ACE Incubator

Global footprint

Where Nicolab has talent and traffic

Workforce by country
10 countries with
team presence
🇳🇱 Netherlands52.6%
🇦🇺 Australia18.4%
🇪🇸 Spain5.3%
🇮🇳 India5.3%
🇺🇸 United States5.3%
Top 5 of 10 shown

In the news

Latest news about Nicolab

Recent press, funding announcements, and product moves mentioning Nicolab — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Nicolab

An AI-synthesized read of the highest-engagement posts about Nicolab on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nicolab’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.